MMR and MSI Testing in Patients Being Considered for Checkpoint Inhibitor Therapy
- MeSH Terms
- Neoplasms (C04); Molecular Diagnostic Techniques (E05.200.880); Specimen Handling (E05.200.998); Biological Assay (E05.091); Histological Techniques (E05.200.750); Cytological Techniques (E05.200.500); Tumor Markers; Biological (D23.101.840)
- Guideline Contact
- Christina Ventura ([email protected])
- Publication Date
- 03-Aug-22
- Publication Scope
- assessment
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- CAP (US)
- Publication Year
- 2022